• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Enhancing the comparability of costing methods: cross-country variability in the prices of non-traded inputs to health programmes.提高成本核算方法的可比性:卫生项目非贸易投入价格的跨国差异
Cost Eff Resour Alloc. 2006 Apr 24;4:8. doi: 10.1186/1478-7547-4-8.
2
Tuberculosis结核病
3
Programme costs in the economic evaluation of health interventions.卫生干预措施经济评估中的项目成本。
Cost Eff Resour Alloc. 2003 Feb 26;1(1):1. doi: 10.1186/1478-7547-1-1.
4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
Costing malaria interventions from pilots to elimination programmes.从试点项目到消除规划的疟疾干预成本。
Malar J. 2020 Sep 14;19(1):332. doi: 10.1186/s12936-020-03405-3.
6
7
Determinants of variation in the cost of inpatient stays versus outpatient visits in hospitals: a multi-country analysis.医院住院与门诊就诊费用差异的决定因素:一项多国分析。
Soc Sci Med. 2006 Oct;63(7):1700-10. doi: 10.1016/j.socscimed.2006.04.023.
8
Cost-Effectiveness and Affordability of Interventions, Policies, and Platforms for the Prevention and Treatment of Mental, Neurological, and Substance Use Disorders预防和治疗精神、神经及物质使用障碍的干预措施、政策和平台的成本效益及可负担性
9
Disease control programme support costs: an update of WHO-CHOICE methodology, price databases and quantity assumptions.疾病控制规划支持成本:世界卫生组织成本核算工具(WHO-CHOICE)方法、价格数据库及数量假设的更新
Cost Eff Resour Alloc. 2017 Oct 26;15:21. doi: 10.1186/s12962-017-0083-6. eCollection 2017.
10
Health economics in developing countries.发展中国家的卫生经济学
J Trop Med Hyg. 1989 Aug;92(4):229-41.

引用本文的文献

1
Lifestyle Interventions to Prevent Type 2 Diabetes: A Systematic Review of Economic Evaluation Studies.预防2型糖尿病的生活方式干预:经济评估研究的系统评价
J Diabetes Res. 2016;2016:2159890. doi: 10.1155/2016/2159890. Epub 2016 Jan 13.
2
Costing the supply chain for delivery of ACT and RDTs in the public sector in Benin and Kenya.贝宁和肯尼亚公共部门抗疟治疗药物(ACT)和快速诊断检测(RDT)供应链的成本核算。
Malar J. 2015 Feb 5;14:57. doi: 10.1186/s12936-014-0530-1.
3
Cost effectiveness of strategies to combat road traffic injuries in sub-Saharan Africa and South East Asia: mathematical modelling study.撒哈拉以南非洲和东南亚道路交通事故伤害防治策略的成本效益:数学模型研究。
BMJ. 2012 Mar 2;344:e612. doi: 10.1136/bmj.e612.
4
Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches.疫苗接种计划的成本效益分析:建模方法的重点综述
Pharmacoeconomics. 2008;26(3):191-215. doi: 10.2165/00019053-200826030-00004.
5
Estimated global resources needed to attain international malaria control goals.实现国际疟疾控制目标所需的全球资源估计数。
Bull World Health Organ. 2007 Aug;85(8):623-30. doi: 10.2471/blt.06.039529.
6
Estimated global resources needed to attain universal coverage of maternal and newborn health services.实现孕产妇和新生儿保健服务全民覆盖所需的全球资源估计数。
Bull World Health Organ. 2007 Apr;85(4):256-63. doi: 10.2471/blt.06.032037.
7
Methods to assess the costs and health effects of interventions for improving health in developing countries.评估发展中国家改善健康干预措施的成本和健康影响的方法。
BMJ. 2005 Nov 12;331(7525):1137-40. doi: 10.1136/bmj.331.7525.1137.

本文引用的文献

1
Human resources for health: overcoming the crisis.卫生人力资源:克服危机。
Lancet. 2004;364(9449):1984-90. doi: 10.1016/S0140-6736(04)17482-5.
2
How to bridge the gap in human resources for health.如何弥补卫生人力资源方面的差距。
Lancet. 2004;364(9443):1451-6. doi: 10.1016/S0140-6736(04)17229-2.
3
Migration of health-care workers from developing countries: strategic approaches to its management.发展中国家医护人员的流失:管理流失问题的战略方法
Bull World Health Organ. 2004 Aug;82(8):595-600. Epub 2004 Sep 13.
4
Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost?实现世界卫生组织/联合国艾滋病规划署的“3年内使500万人接受抗逆转录病毒治疗”目标:这将花费多少?
Lancet. 2004;364(9428):63-4. doi: 10.1016/S0140-6736(04)16590-2.
5
Health workforce imbalances in times of globalization: brain drain or professional mobility?全球化时代卫生人力的不平衡:人才流失还是职业流动?
Int J Health Plann Manage. 2003 Oct-Dec;18 Suppl 1:S89-101. doi: 10.1002/hpm.720.
6
Cost-effectiveness analysis: can we reduce variability in costing methods?成本效益分析:我们能否减少成本计算方法的变异性?
Int J Technol Assess Health Care. 2003 Spring;19(2):407-20. doi: 10.1017/s0266462303000369.
7
Programme costs in the economic evaluation of health interventions.卫生干预措施经济评估中的项目成本。
Cost Eff Resour Alloc. 2003 Feb 26;1(1):1. doi: 10.1186/1478-7547-1-1.
8
Econometric estimation of country-specific hospital costs.特定国家医院成本的计量经济学估计。
Cost Eff Resour Alloc. 2003 Feb 26;1(1):3. doi: 10.1186/1478-7547-1-3.
9
Cost-effectiveness of chemotherapy for sputum smear-positive pulmonary tuberculosis in Malawi, Mozambique and Tanzania.马拉维、莫桑比克和坦桑尼亚痰涂片阳性肺结核化疗的成本效益
Int J Health Plann Manage. 1994 Apr-Jun;9(2):151-81. doi: 10.1002/hpm.4740090204.

提高成本核算方法的可比性:卫生项目非贸易投入价格的跨国差异

Enhancing the comparability of costing methods: cross-country variability in the prices of non-traded inputs to health programmes.

作者信息

Johns Benjamin, Adam Taghreed, Evans David B

机构信息

Health System Financing (EIP/HSF), World Health Organization, 9th Floor Bina Mulia-I Building, Jl Rasuna Said Kav, 10, Kuningan Jakarta 12950, Indonesia.

出版信息

Cost Eff Resour Alloc. 2006 Apr 24;4:8. doi: 10.1186/1478-7547-4-8.

DOI:10.1186/1478-7547-4-8
PMID:16630364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1563478/
Abstract

BACKGROUND

National and international policy makers have been increasing their focus on developing strategies to enable poor countries achieve the millennium development goals. This requires information on the costs of different types of health interventions and the resources needed to scale them up, either singly or in combinations. Cost data also guides decisions about the most appropriate mix of interventions in different settings, in view of the increasing, but still limited, resources available to improve health. Many cost and cost-effectiveness studies include only the costs incurred at the point of delivery to beneficiaries, omitting those incurred at other levels of the system such as administration, media, training and overall management. The few studies that have measured them directly suggest that they can sometimes account for a substantial proportion of total costs, so that their omission can result in biased estimates of the resources needed to run a programme or the relative cost-effectiveness of different choices. However, prices of different inputs used in the production of health interventions can vary substantially within a country. Basing cost estimates on a single price observation runs the risk that the results are based on an outlier observation rather than the typical costs of the input.

METHODS

We first explore the determinants of the observed variation in the prices of selected "non-traded" intermediate inputs to health programmes--printed matter and media advertising, and water and electricity--accounting for variation within and across countries. We then use the estimated relationship to impute average prices for countries where limited data are available with uncertainty intervals.

RESULTS

Prices vary across countries with GDP per capita and a number of determinants of supply and demand. Media and printing were inelastic with respect to GDP per capita, with a positive correlation, while the utilities had a surprisingly negative relationship. All equations had relatively good fits with the data.

CONCLUSION

While the preferred option is to derive costs from a random sample of prices in each setting, this option is often not available to analysts. In this case, we suggest that the approach described in this paper could represent a better option than basing policy recommendations on results that are built on the basis of a single, or a few, price observations.

摘要

背景

国家和国际政策制定者越来越关注制定战略,以使贫困国家实现千年发展目标。这需要了解不同类型卫生干预措施的成本以及扩大这些措施规模(单独或组合)所需的资源。鉴于用于改善健康的资源虽在增加但仍有限,成本数据还指导着关于在不同环境中最适当干预措施组合的决策。许多成本和成本效益研究仅包括向受益人提供服务时产生的成本,而忽略了系统其他层面(如行政、媒体、培训和总体管理)产生的成本。少数直接测量这些成本的研究表明,它们有时可能占总成本的很大比例,因此忽略这些成本可能导致对开展一项计划所需资源或不同选择的相对成本效益的估计产生偏差。然而,一个国家内用于生产卫生干预措施的不同投入品价格可能有很大差异。基于单一价格观察来估计成本存在这样的风险,即结果是基于异常值观察而非投入品的典型成本。

方法

我们首先探究选定的卫生计划“非贸易”中间投入品(印刷品和媒体广告以及水和电)价格观察到的变化的决定因素,同时考虑国家内部和国家之间的差异。然后,我们利用估计的关系为数据有限的国家推算平均价格及不确定区间。

结果

价格因国家而异,与人均国内生产总值以及一些供求决定因素有关。媒体和印刷业相对于人均国内生产总值缺乏弹性,呈正相关,而公用事业则呈现出令人惊讶的负相关关系。所有方程与数据的拟合度都相对较好。

结论

虽然首选方法是从每个环境中的价格随机样本得出成本,但分析人员往往无法采用这种方法。在这种情况下,我们建议本文所述方法可能比基于单个或少数价格观察结果制定政策建议更好。